Last $12.63 USD
Change Today -0.35 / -2.70%
Volume 1.8M
INO On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

J. Joseph Kim Ph.D.

Chief Executive Officer, President, Director and Member of Finance Committee, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 3 different organizations across 4 different industries.

See Board Relationships
45$1,031,765
As of Fiscal Year 2013

Background*

Dr. J. Joseph Kim, Ph.D has been the Chief Executive Officer of Inovio Pharmaceuticals, Inc (alternate name: Inovio Biomedical Corp) since June 1, 2009 and has been its President since October 6, 2009. Dr. Kim co-founded ADViSYS Inc., a subsidiary of Viral Genomix in 1997 and serves as its Chief Executive Officer and President. He co-founded VGX Pharmaceuticals, LLC (Formerly Viral Genomix, Inc) in 2000 and served as its Chief Executive Officer and President from 2000 ...

Read Full Background

Corporate Headquarters*

Building 18
Blue Bell, Pennsylvania 19422

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director
Chairman
2000-2009
Co-Founder
2009-Present
Chief Executive Officer, President, Director and Member of Finance Committee

Education*

BS
Massachusetts Institute of Technology
PhD
The University of Pennsylvania
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$539,838
Bonus$312,998
Total Annual Compensation$852,836

Stock Options*

All Other Compensation$8,381
Exercisable Options2,793,960
Unexercisable Options592,500
Total Number of Options3,386,460

Total Compensation*

Total Annual Cash Compensation$861,217
Total Short Term Compensation$852,836
Other Long Term Compensation$8,381
Total Calculated Compensation$1,031,765
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $12.63 USD -0.35

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
$448.3K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Philippe Archinard Ph.D.Chairman and Chief Executive Officer
Transgene SA
€72.2K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.